Mastering Medical
USMLE Step 1 · Biochemistry & Genetics

GM2 and sphingomyelin lysosomal storage diseases vs Glucocerebrosidase, alpha-galactosidase, galactocerebrosidase, and mucopolysaccharide disorders

How to tell GM2 and sphingomyelin lysosomal storage diseases and Glucocerebrosidase, alpha-galactosidase, galactocerebrosidase, and mucopolysaccharide disorders apart when a board question makes them look alike.

Fastest separator

Tay-Sachs is GM2 neurodegeneration without hepatosplenomegaly; Niemann-Pick adds foam cells/hepatosplenomegaly; Gaucher is bone crises; Fabry is angiokeratoma renal/cardiac disease.

Side by side

GM2 and sphingomyelin lysosomal storage diseasesGlucocerebrosidase, alpha-galactosidase, galactocerebrosidase, and mucopolysaccharide disorders
Key clue

Tay-Sachs and Sandhoff cause neurodegeneration with cherry-red macula from GM2 accumulation; Niemann-Pick causes neurodegeneration, hepatosplenomegaly, foam cells, and sphingomyelin accumulation.

Gaucher has hepatosplenomegaly and bone crises; Fabry has angiokeratomas and renal/cardiac disease; Krabbe has peripheral neuropathy; Hurler/Hunter have coarse facies and glycosaminoglycans.

Mechanism

Hexosaminidase defects impair GM2 degradation, while sphingomyelinase or NPC defects disrupt sphingomyelin/cholesterol handling.

Other lysosomal enzyme defects accumulate glucocerebroside, ceramide trihexoside, galactocerebroside, or glycosaminoglycans in tissue-specific patterns.

Labs and tests

Cherry-red spot without hepatosplenomegaly favors Tay-Sachs; cherry-red spot with hepatosplenomegaly supports Niemann-Pick/Sandhoff patterns.

Glucocerebrosidase deficiency, angiokeratomas, psychosine, or dermatan/heparan sulfate accumulation points to the non-GM2 storage disorders.

The trap

Cherry-red macula is not specific; hepatosplenomegaly, foam cells, bone pain, angiokeratomas, and coarse facies separate storage diseases.

The repair move

For lysosomal storage, first decide the stored substrate and whether hepatosplenomegaly is present.

Try a free question

Core

An 8-month-old infant of Ashkenazi Jewish descent has lost previously acquired milestones, has an exaggerated startle to sound, and on funduscopy has a cherry-red macula. Liver and spleen are NOT enlarged. Hexosaminidase A activity is markedly reduced. Which lysosomal storage disease is most likely?

Show answer and explanation

Answer: A. Tay-Sachs disease (GM2 gangliosidosis). Tay-Sachs disease is hexosaminidase A deficiency producing GM2 ganglioside accumulation in neurons; the hallmark is progressive neurodegeneration with cherry-red macula and exaggerated startle WITHOUT hepatosplenomegaly.

Why the other choices are tempting

  • B. Gaucher disease is glucocerebrosidase deficiency producing hepatosplenomegaly, bone crises, and Gaucher cells (macrophages with crumpled tissue paper cytoplasm), not isolated neurodegeneration without organomegaly.
  • C. Fabry disease is alpha-galactosidase A deficiency producing angiokeratomas, peripheral neuropathy, and renal/cardiac disease, not infantile cherry-red macula.
  • D. Hurler syndrome causes coarse facies, corneal clouding, and hepatosplenomegaly from glycosaminoglycan accumulation.
  • E. Krabbe disease causes peripheral demyelination with globoid cells from galactocerebrosidase deficiency.

Flashcards

Tap a card to flip it.

What clue supports GM2 and sphingomyelin lysosomal storage diseases?

Choose GM2 and sphingomyelin lysosomal storage diseases when the stem gives this pattern: Tay-Sachs and Sandhoff cause neurodegeneration with cherry-red macula from GM2 accumulation; Niemann-Pick causes neurodegeneration, hepatosplenomegaly, foam cells, and sphingomyelin accumulation.

What clue supports Glucocerebrosidase, alpha-galactosidase, galactocerebrosidase, and mucopolysaccharide disorders?

Choose Glucocerebrosidase, alpha-galactosidase, galactocerebrosidase, and mucopolysaccharide disorders when the stem gives this contrasting pattern: Gaucher has hepatosplenomegaly and bone crises; Fabry has angiokeratomas and renal/cardiac disease; Krabbe has peripheral neuropathy; Hurler/Hunter have coarse facies and glycosaminoglycans.

Quick answers

What is the fastest way to tell GM2 and sphingomyelin lysosomal storage diseases from Glucocerebrosidase, alpha-galactosidase, galactocerebrosidase, and mucopolysaccharide disorders?

Tay-Sachs is GM2 neurodegeneration without hepatosplenomegaly; Niemann-Pick adds foam cells/hepatosplenomegaly; Gaucher is bone crises; Fabry is angiokeratoma renal/cardiac disease.

What is the key clue for GM2 and sphingomyelin lysosomal storage diseases?

Tay-Sachs and Sandhoff cause neurodegeneration with cherry-red macula from GM2 accumulation; Niemann-Pick causes neurodegeneration, hepatosplenomegaly, foam cells, and sphingomyelin accumulation.

What is the key clue for Glucocerebrosidase, alpha-galactosidase, galactocerebrosidase, and mucopolysaccharide disorders?

Gaucher has hepatosplenomegaly and bone crises; Fabry has angiokeratomas and renal/cardiac disease; Krabbe has peripheral neuropathy; Hurler/Hunter have coarse facies and glycosaminoglycans.

What is the common trap with GM2 and sphingomyelin lysosomal storage diseases vs Glucocerebrosidase, alpha-galactosidase, galactocerebrosidase, and mucopolysaccharide disorders?

Cherry-red macula is not specific; hepatosplenomegaly, foam cells, bone pain, angiokeratomas, and coarse facies separate storage diseases.